xml version="1.0" encoding="UTF-8"?        Document  

false0000200406  0000200406  jnj:A0.250NotesDue2022Member    2020-01-22 2020-01-22    0000200406  jnj:A1.650NotesDue2035Member    2020-01-22 2020-01-22    0000200406  jnj:A1.150NotesDue2028Member    2020-01-22 2020-01-22    0000200406  jnj:A0.650NotesDue2024Member    2020-01-22 2020-01-22    0000200406  jnj:A5.50NotesDue2024Member    2020-01-22 2020-01-22    0000200406  us-gaap:CommonStockMember    2020-01-22 2020-01-22    0000200406   2020-01-22 2020-01-22  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): 

January 22, 2020 

Johnson & Johnson 

 (Exact name of registrant as specified in its charter)

[DATA_TABLE_REMOVED]

One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 

(Address of Principal Executive Offices)

 (Zip Code) 

Registrant's telephone number, including area code:

732-524-0400 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17

 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17

 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

[DATA_TABLE_REMOVED]

Item 2.02 Results of Operations and Financial Condition

On January 22, 2020, Johnson & Johnson issued the attached press release announcing its sales and earnings for the fourth quarter and full year ended December 29, 2019.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. 

[DATA_TABLE_REMOVED]

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

[DATA_TABLE_REMOVED]